Alfredo Carrato
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications
Current patterns of next-generation sequencing testing in biliary tract cancer patients in Spain.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 29, 2026
Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: October 13, 2025
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe.
Journal: United European gastroenterology journal
Published: July 12, 2025
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis.
Journal: Nature communications
Published: November 27, 2024
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
Journal: Cancer management and research
Published: August 29, 2024
Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk.
Journal: International journal of cancer
Published: August 08, 2024
Combined analysis of a serum mRNA/miRNA marker signature and CA 19-9 for timely and accurate diagnosis of recurrence after resection of pancreatic ductal adenocarcinoma: A prospective multicenter cohort study.
Journal: United European gastroenterology journal
Published: May 07, 2024
Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Journal: NEJM evidence
Published: February 06, 2024
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants.
Journal: Familial cancer
Published: February 02, 2024
The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer.
Journal: Familial cancer
Published: December 30, 2023
Last Updated: 09/26/2026